We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Controversies in Neurology |

Questioning Botulinum Toxin for Headache Reality or Illusion

E. S. Roach, MD
Arch Neurol. 2008;65(1):151-152. doi:10.1001/archneurol.2007.24.
Text Size: A A A
Published online


Since the first anecdotal reports1 of headache improvement in individuals receiving botulinum injections for facial wrinkles, several controlled and uncontrolled trials of botulinum neurotoxin (BoNT) in headache patients have been published. These studies have yielded generally disappointing and conflicting results, and there continues to be controversy about the usefulness of BoNT in individuals with headache. In this “Controversies in Neurology,” Ashkenazi and Silberstein2 argue that BoNT is a safe and effective headache treatment for some individuals with episodic or chronic migraine while Pakalnis and Couch3 believe that the available randomized clinical trials provide little evidence that botulinum injections benefit individuals with either migraine or tension headache. Although Pakalnis and Couch acknowledge that a small subset of headache patients might benefit from BoNT therapy, there is presently no way to identify these individuals short of treating them.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

8 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Original Article: Does This Patient Have a Hemorrhagic Stroke?

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Quick Reference